TYR and melanoma: So, in our chained studies for the synthesis of new calixdrugs, calixarene-based clusters of established therapeutic drug agents, in the present study, the authors introduce novel cyclic tetramer of arbutin, based on calixarene scaffold as its cluster with potential anti-tyrosinase and anti-melanoma activities (1).